3D Global Biotech Inc. (6808) Stock Statistics & Valuation Metrics
Total Valuation
3D Global Biotech Inc. has a market cap or net worth of TWD 2.04B. The enterprise value is ―.
- Market Cap
- TWD 2.04B
- Enterprise Value
- ―
Share Statistics
3D Global Biotech Inc. has 76,809,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 76,809,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
3D Global Biotech Inc.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.92%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 3.92%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 4.81M
- Profits Per Employee
- 1.55M
- Employee Count
- 43
- Asset Turnover
- 0.19
- Inventory Turnover
- 3.54
Valuation Ratios
The current PE Ratio of 3D Global Biotech Inc. is 136.84. 3D Global Biotech Inc.’s PEG ratio is -1.52.
- PE Ratio
- 136.84
- PS Ratio
- 12.57
- PB Ratio
- 2.73
- Price to FCF
- 37.85
- Price to Operating Cash Flow
- 30.36
- PEG Ratio
- -1.52
Income Statement
In the last 12 months, 3D Global Biotech Inc. had revenue of 206.74M and earned 66.53M in profits. Earnings per share was 0.86.
- Revenue
- 206.74M
- Gross Profit
- 127.50M
- Operating Income
- 41.45M
- Pretax Income
- 52.30M
- Net Income
- 66.53M
- EBITDA
- 69.10M
- Earnings Per Share (EPS)
- 0.86
Cash Flow
In the last 12 months, operating cash flow was 65.93M and capital expenditures -13.05M, giving a free cash flow of 52.88M billion.
- Operating Cash Flow
- 65.93M
- Free Cash Flow
- 52.88M
- Free Cash Flow per Share
- 0.69
Dividends & Yields
3D Global Biotech Inc. pays an annual dividend of ―, resulting in a dividend yield of 0.50%
- Dividend Per Share
- ―
- Dividend Yield
- 0.50%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.64%
- Earnings Yield
- 0.71%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- -43.39%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 27.60
- Average Volume (3m)
- 110.25K
Financial Position
3D Global Biotech Inc. as a current ratio of 14.08, with Debt / Equity ratio of 4.94%
- Current Ratio
- 14.08
- Quick Ratio
- 13.53
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.45
- Interest Coverage Ratio
- 29.59
Taxes
In the past 12 months, 3D Global Biotech Inc. has paid -14.22M in taxes.
- Income Tax
- -14.22M
- Effective Tax Rate
- -0.27
Enterprise Valuation
3D Global Biotech Inc. EV to EBITDA ratio is 106.51, with an EV/FCF ratio of 38.13.
- EV to Sales
- 12.67
- EV to EBITDA
- 106.51
- EV to Free Cash Flow
- 38.13
- EV to Operating Cash Flow
- 30.58
Balance Sheet
3D Global Biotech Inc. has TWD 497.11M in cash and marketable securities with TWD 45.16M in debt, giving a net cash position of TWD 451.95M billion.
- Cash & Marketable Securities
- TWD 497.11M
- Total Debt
- TWD 45.16M
- Net Cash
- TWD 451.95M
- Net Cash Per Share
- TWD 5.88
- Tangible Book Value Per Share
- TWD 8.66
Margins
Gross margin is 54.94%, with operating margin of -3.86%, and net profit margin of 8.92%.
- Gross Margin
- 54.94%
- Operating Margin
- -3.86%
- Pretax Margin
- 12.61%
- Net Profit Margin
- 8.92%
- EBITDA Margin
- 11.89%
- EBIT Margin
- -3.86%
Analyst Forecast
The average price target for 3D Global Biotech Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -51.00%
- EPS Growth Forecast
- -90.29%
